Literature DB >> 21374682

Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease.

Peter Witters, Louis Libbrecht, Tania Roskams, Kris De Boeck, Lieven Dupont, Marijke Proesmans, François Vermeulen, Birgitta Strandvik, Anders Lindblad, Xavier Stéphenne, Etienne Sokal, Serge Gosseye, Sam Heye, Geert Maleux, Raymond Aerts, Diethard Monbaliu, Jacques Pirenne, Ilse Hoffman, Frederik Nevens, David Cassiman.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21374682     DOI： 10.1002/hep.24183

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  11 in total

Review 1.  Cystic fibrosis liver disease: A condition in need of structured transition and continuity of care.

Authors:  Julian Hercun; Fernando Alvarez; Catherine Vincent; Marc Bilodeau
Journal:  Can Liver J       Date:  2019-08-27

2.  Heterogeneous Liver on Research Ultrasound Identifies Children with Cystic Fibrosis at High Risk of Advanced Liver Disease: Interim Results of a Prospective Observational Case-Controlled Study.

Authors:  Marilyn J Siegel; A Jay Freeman; Wen Ye; Joseph J Palermo; Jean P Molleston; Shruti M Paranjape; Janis Stoll; Daniel H Leung; Prakash Masand; Boaz Karmazyn; Roger Harned; Simon C Ling; Oscar M Navarro; Wikrom Karnsakul; Adina Alazraki; Sarah Jane Schwarzenberg; Frank Glen Seidel; Alex Towbin; Estella M Alonso; Jennifer L Nicholas; Karen F Murray; Randolph K Otto; Averell H Sherker; John C Magee; Michael R Narkewicz
Journal:  J Pediatr       Date:  2020-02-12       Impact factor: 4.406

Review 3.  Cystic fibrosis from the gastroenterologist's perspective.

Authors:  Chee Y Ooi; Peter R Durie
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

Review 4.  Cirrhosis and other liver disease in cystic fibrosis.

Authors:  Thomas Flass; Michael R Narkewicz
Journal:  J Cyst Fibros       Date:  2012-12-20       Impact factor: 5.482

Review 5.  Idiopathic noncirrhotic portal hypertension: current perspectives.

Authors:  Oliviero Riggio; Stefania Gioia; Ilaria Pentassuglio; Valeria Nicoletti; Michele Valente; Giulia d'Amati
Journal:  Hepat Med       Date:  2016-07-27

6.  Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.

Authors:  Pierre-Yves Boëlle; Dominique Debray; Loic Guillot; Annick Clement; Harriet Corvol
Journal:  Hepatology       Date:  2018-12-28       Impact factor: 17.425

7.  Association Between Transient Elastography and Controlled Attenuated Parameter and Liver Ultrasound in Children With Cystic Fibrosis.

Authors:  Wen Ye; Daniel H Leung; Jean P Molleston; Simon C Ling; Karen F Murray; Jennifer L Nicholas; Suiyuan Huang; Boaz W Karmazyn; Roger K Harned; Prakash Masand; Adina L Alazraki; Oscar M Navarro; Randolph K Otto; Joseph J Palermo; Alexander J Towbin; Estella M Alonso; Wikrom W Karnsakul; Sarah Jane Schwarzenberg; Glenn F Seidel; Marilyn Siegel; John C Magee; Michael R Narkewicz; A Jay Freeman
Journal:  Hepatol Commun       Date:  2021-05-13

8.  Relevance of 3D Cholangiography and Transient Elastography to Assess Cystic Fibrosis-Associated Liver Disease?

Authors:  C Lemaitre; S Dominique; E Billoud; M Eliezer; H Montialoux; M Quillard; G Riachi; E Koning; H Morisse-Pradier; G Savoye; C Savoye-Collet; O Goria
Journal:  Can Respir J       Date:  2016-06-26       Impact factor: 2.409

9.  Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents.

Authors:  Ana Luiza Melo Dos Santos; Helen de Melo Santos; Marina Bettiol Nogueira; Hugo Tadashi Oshiro Távora; Maria de Lourdes Jaborandy Paim da Cunha; Renata Belém Pessoa de Melo Seixas; Luciana de Freitas Velloso Monte; Elisa de Carvalho
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2018-10-10

Review 10.  Current Treatment Options for Cystic Fibrosis-Related Liver Disease.

Authors:  Katharina Staufer
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.